[go: up one dir, main page]

DE60015306D1 - Verwendung von beta interferon zur herstellung eines arzneimittels zur behandlung von ewings sarkom und eoe - Google Patents

Verwendung von beta interferon zur herstellung eines arzneimittels zur behandlung von ewings sarkom und eoe

Info

Publication number
DE60015306D1
DE60015306D1 DE60015306T DE60015306T DE60015306D1 DE 60015306 D1 DE60015306 D1 DE 60015306D1 DE 60015306 T DE60015306 T DE 60015306T DE 60015306 T DE60015306 T DE 60015306T DE 60015306 D1 DE60015306 D1 DE 60015306D1
Authority
DE
Germany
Prior art keywords
treatment
sarkom
ewings
eoe
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60015306T
Other languages
English (en)
Other versions
DE60015306T2 (de
Inventor
Josiane Sanceau
Jeanne Wietzerbin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Institut Curie
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Institut Curie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Institut Curie filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Application granted granted Critical
Publication of DE60015306D1 publication Critical patent/DE60015306D1/de
Publication of DE60015306T2 publication Critical patent/DE60015306T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60015306T 1999-04-09 2000-04-10 Verwendung von beta interferon zur herstellung eines arzneimittels zur behandlung von ewings sarkom und eoe Expired - Lifetime DE60015306T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9904480 1999-04-09
FR9904480A FR2791894B1 (fr) 1999-04-09 1999-04-09 Utilisation d'interferon beta dans le traitement de la tumeur d'ewing
PCT/EP2000/004171 WO2000061172A1 (en) 1999-04-09 2000-04-10 Interferon-beta use in the treatment of ewing's family of tumors

Publications (2)

Publication Number Publication Date
DE60015306D1 true DE60015306D1 (de) 2004-12-02
DE60015306T2 DE60015306T2 (de) 2006-03-02

Family

ID=9544241

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60015306T Expired - Lifetime DE60015306T2 (de) 1999-04-09 2000-04-10 Verwendung von beta interferon zur herstellung eines arzneimittels zur behandlung von ewings sarkom und eoe

Country Status (9)

Country Link
US (1) US6749846B1 (de)
EP (1) EP1165117B1 (de)
AT (1) ATE280584T1 (de)
AU (1) AU4918900A (de)
CA (1) CA2369427C (de)
DE (1) DE60015306T2 (de)
ES (1) ES2234605T3 (de)
FR (1) FR2791894B1 (de)
WO (1) WO2000061172A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20030130A0 (fi) 2003-01-29 2003-01-29 Licentia Oy Seulontamenetelmä

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4128319A1 (de) * 1991-08-27 1993-03-04 Bioferon Biochem Substanz Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
EP0783891B1 (de) * 1995-07-25 2006-12-27 Toray Industries, Inc. Interferon-beta gegen knochenerkrankungen

Also Published As

Publication number Publication date
EP1165117B1 (de) 2004-10-27
DE60015306T2 (de) 2006-03-02
WO2000061172A1 (en) 2000-10-19
FR2791894A1 (fr) 2000-10-13
FR2791894B1 (fr) 2001-07-13
CA2369427C (en) 2011-01-04
ATE280584T1 (de) 2004-11-15
CA2369427A1 (en) 2000-10-19
US6749846B1 (en) 2004-06-15
ES2234605T3 (es) 2005-07-01
AU4918900A (en) 2000-11-14
EP1165117A1 (de) 2002-01-02

Similar Documents

Publication Publication Date Title
DE69533112D1 (de) Verwendung von flavolignanen zur herstellung von medikamenten mit antiproliferativer aktivität in gebärmutter,brust,eierstöcken
DE69914463D1 (en) Therapeutische chemokine rezeptor antagonisten
HUT60630A (en) Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
DE69333321D1 (de) Verwendung eines Consensus-Interferons zur Reduzierung der Nebeneffekte in der Interferon Behandlung von viralen Hepatiten.
ATE205389T1 (de) Verwendung von lokalanaesthetika zur herstellung eines arzneimittels zur behandlung von bronchialasthma
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
BG106095A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
DE69713526D1 (de) Lösliche prodrugs von paclitaxel
ATE332702T1 (de) Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen
ATE451096T1 (de) Peptidderivate oder deren pharmazeutisch annehmbare salze, verfahren zu deren herstellung, verwendung dieser derivate und arzneimittel
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
ATE197670T1 (de) Parenterales busulfan zur behandlung von malignen krankheiten
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
KR910005858A (ko) 지방산 요법
ATE230609T1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
DE69130063D1 (de) Antivirales arzneimittel enthaltend prostratin
DE69733169D1 (de) Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs
DE60015306D1 (de) Verwendung von beta interferon zur herstellung eines arzneimittels zur behandlung von ewings sarkom und eoe
RU2003100517A (ru) Новый интерферон для лечения рассеянного склероза
GEP20012511B (en) Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
DE69434002D1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
IL126795A (en) Pharmaceutical compositions for the treatment of substance abuse disorders comprising pyridyl- and pyrimidyl-piperazines
DE69233773D1 (de) Verwendung von topotecan zur herstellung eines medikaments zur verwendung in der behandlung von ovarialkrebs

Legal Events

Date Code Title Description
8364 No opposition during term of opposition